Abstract:The clinical application of doxorubicin (DOX), like other anticancer drugs, is limited by insufficient cellular uptake and the numerous drug resistance mechanisms existing in cells. The development of smart nanomaterials capable of carrying the drugs into the cells and of releasing them under the control of the microenvironment is an interesting approach that may increase the success of the anticancer drugs currently in use. Herein, we report an easy process to prepare biocompatible nanogels (NGs) with thermo/redox/pH-triple sensitivity, which are highly effective in the intracellular delivery of DOX. Redox-sensitive/degradable NGs (PNA-BAC) and nondegradable NGs (PNA-MBA) were prepared through in situ polymerization of N-isopropylacrylamide (NIPAM) and acrylic acid (AA) in the presence of sodium dodecyl sulfate (SDS) as a surfactant, using N,N'-bis(acryloyl)cystamine (BAC) as a biodegradable crosslinker or N,N'-methylene bisacrylamide (MBA) as a nondegradable crosslinker, respectively. After that, the cationic DOX drug was loaded into the NGs through electrostatic interactions, by simply mixing them in aqueous solution. Compared to nondegradable PNA-MBA NGs, PNA-BAC NGs not only presented a higher DOX drug loading capacity, but also allowed a more sustainable drug release behavior under physiological conditions. More importantly, PNA-BAC NGs displayed thermo-induced drug release properties and an in vitro accelerated release of DOX under conditions that mimic intracellular reductive conditions and acidic tumor microenvironments. The thermo/redox/pH multi-sensitive NGs can quickly be taken up by CAL-72 cells (an osteosarcoma cell line), resulting in a high DOX intracellular accumulation and an improved cytotoxicity when compared with free DOX and DOX-loaded nondegradable PNA-MBA NGs. The developed NGs can be possibly used as an effective platform for the delivery of cationic therapeutic agents for biomedical applications.

Redox-responsive Hyaluronic Acid Nanogels for Hyperthermia- Assisted Chemotherapy to Overcome Multidrug Resistance.

Gold Nanorods Functionalized With Cathepsin B Targeting Peptide And Doxorubicin For Combinatorial Therapy Against Multidrug Resistance

Temperature and Redox Dual‐Responsive Biodegradable Nanogels for Optimizing Antitumor Drug Delivery

Hydrophilicity/Hydrophobicity Reversable and Redox-Sensitive Nanogels for Anticancer Drug Delivery.

Self-targeting visualizable hyaluronate nanogel for synchronized intracellular release of doxorubicin and cisplatin in combating multidrug-resistant breast cancer

Zwitterionic Temperature/Redox-Sensitive Nanogels for Near-Infrared Light-Triggered Synergistic Thermo-Chemotherapy.

Thermo/redox/pH-triple Sensitive Poly(n-Isopropylacrylamide-co-acrylic Acid) Nanogels for Anticancer Drug Delivery.

Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging

Acid-sensitive and L61-crosslinked Hyaluronic Acid Nanogels for Overcoming Tumor Drug-Resistance.

A dual-responsive hyaluronic acid nanocomposite hydrogel drug delivery system for overcoming multiple drug resistance

Hydrophobicity-Adaptive Nanogels for Programmed Anticancer Drug Delivery

Smart Ph/redox Dual-Responsive Nanogels for On-Demand Intracellular Anticancer Drug Release

Thermosensitive Hydrogel Co-loaded with Gold Nanoparticles and Doxorubicin for Effective Chemoradiotherapy

NIR and UV-responsive Degradable Hyaluronic Acid Nanogels for CD44-targeted and Remotely Triggered Intracellular Doxorubicin Delivery

A redox stimuli-responsive superparamagnetic nanogel with chemically anchored DOX for enhanced anticancer efficacy and low systemic adverse effects

Thermosensitive hydrogel-functionalized gold nanorod/mesoporous MnO<sub>2</sub> nanoparticles for tumor cell-triggered drug delivery

Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, Both Primary and Metastatic Tumors

Hyaluronic Acid-Functionalized Gold Nanorods with Ph/nir Dual-Responsive Drug Release for Synergetic Targeted Photothermal Chemotherapy of Breast Cancer

NIR-Controlled Treatment of Multidrug-Resistant Tumor Cells by Mesoporous Silica Capsules Containing Gold Nanorods and Doxorubicin

Injectable hydrogel-mediated combination of hyperthermia ablation and photo-enhanced chemotherapy in the NIR-II window for tumor eradication

Peptide Multifunctionalized Gold Nanorods with Dual pH/NIR Responsive Release of Doxorubicin for High-Efficiency Cancer Treatment.